5Fam-CRGDK-OH

Ref. 3D-PP45141

Produktinformation

• Name: 5Fam-CRGDK-OH
• Synonyme: 5Fam-Cys-Arg-Gly-Asp-Lys-OH

Beschreibung

Peptide 5Fam-CRGDK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using 5Fam-CRGDK-OH include the following: Internalizing RGD, a great motif for targeted peptide and protein delivery: a review article Z Davoodi, F Shafiee - Drug Delivery and Translational Research, 2022 - Springerhttps://link.springer.com/article/10.1007/s13346-022-01116-7 Tumor-targeting peptide for redox-responsive Pt prodrug and gene codelivery and synergistic cancer chemotherapy Y Bai, Z Li, L Liu, T Sun, X Fan, T Wang - ACS Applied Bio , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsabm.9b00065 Increased antitumor activity of tumor-specific peptide modified thymopentin X Lao, B Li, M Liu, J Chen, X Gao, H Zheng - Biochimie, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0300908414002624 Does ligand-receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL? WQ Zhang, KF Yu, T Zhong , LM Luo, R Du - Journal of drug , 2015 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.3109/1061186X.2015.1034279 Peptide-functionalized delivery vehicles for enhanced cancer therapy SY Tang, H Wei, CY Yu - International Journal of Pharmaceutics, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517320311261 Peptide-mediated cancer targeting of nanoconjugates S Raha , T Paunesku - Wiley Interdisciplinary , 2011 - Wiley Online Libraryhttps://wires.onlinelibrary.wiley.com/doi/abs/10.1002/wnan.121 Neuropilin-1 Binding Peptide as Fusion to Diphtheria Toxin Induces Apoptosis in Non-small Cell Lung Cancer Cell Line S Eghtedari, M Behdani - Current , 2024 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2024/00000030/00000017/art00003 Developments in tumor targeting and internalizing peptides RIC Padanha - 2017 - repositorio.ul.pthttps://repositorio.ul.pt/handle/10451/36085 Peptide-based nanoprobes for molecular imaging and disease diagnostics P Zhang , Y Cui, CF Anderson , C Zhang, Y Li - Chemical Society , 2018 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2018/cs/c7cs00793k Homing peptides for cancer therapy P Lingasamy , T Teesalu - Bio-nanomedicine for cancer therapy, 2021 - Springerhttps://link.springer.com/chapter/10.1007/978-3-030-58174-9_2 Tumor penetrating peptide-functionalized tenascin-C antibody for glioblastoma targeting P Lingasamy , AH Laarmann - Current cancer drug , 2021 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ccdt/2021/00000021/00000001/art00006 A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer MV Cano-Cortes , SA Navarro-Marchal - , Biology and Medicine, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1549963419302047 Peptide-modified nanoparticles for tumor targeting and molecular imaging L Lu, Q Zhang, Z Wang, L Gao - Current Medicinal , 2021 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2021/00000028/00000031/art00009 De Novo Design of a Tumor-Penetrating Peptide L Alberici, L Roth, KN Sugahara, L Agemy - Cancer research, 2013 - AACRhttps://aacrjournals.org/cancerres/article-abstract/73/2/804/590737 Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32 L Agemy, VR Kotamraju, D Friedmann-Morvinski - Molecular Therapy, 2013 - cell.comhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)30945-5 Tissue-penetrating delivery of compounds and nanoparticles into tumors KN Sugahara, T Teesalu , PP Karmali, VR Kotamraju - Cancer cell, 2009 - cell.comhttps://www.cell.com/cancer-cell/pdf/S1535-6108(09)00382-1.pdf A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis KN Sugahara, P Scodeller , GB Braun - Journal of Controlled , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365915006161 Cell-Penetrating Peptide-Conjugated BF2-Oxasmaragdyrins as NIRF Imaging and Photothermal Agents K Laxman , BPK Reddy , A Robinson - , 2020 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cmdc.202000401 Use of Chitosan from Southern King Crab to Develop Films Functionalized with RGD Peptides for Potential Tissue Engineering Applications JC Forero , K Carvajal, F Guzman, C Acevedo, N Osses - Biomimetics, 2023 - mdpi.comhttps://www.mdpi.com/2313-7673/8/3/323 Integrin-targeting peptides for the design of functional cell-responsive biomaterials J Zhao, F Santino, D Giacomini, L Gentilucci - Biomedicines, 2020 - mdpi.comhttps://www.mdpi.com/2227-9059/8/9/307 Theranostic iRGD peptide containing cisplatin prodrug: Dual-cargo tumor penetration for improved imaging and therapy HJ Cho , SJ Park, YS Lee , S Kim - Journal of controlled release, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365919301269 Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging HJ Cho , SJ Lee, SJ Park, CH Paik, SM Lee - Journal of Controlled , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365916304096 A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity HB Pang , GB Braun , ZG She , VR Kotamraju - Journal of Controlled , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365913009486 iRGD: a promising peptide for cancer imaging and a potential therapeutic agent for various cancers H Zuo - Journal of Oncology, 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2019/9367845 Peptide-decorated polymeric nanomedicines for precision cancer therapy H Sun , Y Dong, J Feijen , Z Zhong - Journal of controlled release, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365918305686 Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery H Song, J Zhang, W Wang , P Huang, Y Zhang - Colloids and Surfaces B , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0927776515301995 Amphipathic tail-anchoring peptide is a promising therapeutic agent for prostate cancer treatment G De, JK Ko , T Tan, H Zhu , H Li , J Ma - Oncotarget, 2014 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202157/ CRGDK-functionalized PAMAM-based drug-delivery system with high permeability D Liu, C Wang, J Yang, Y An, R Yang, G Teng - ACS omega, 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.0c00202 Targeted modification of the cationic anticancer peptide HPRP-A1 with iRGD to improve specificity, penetration, and tumor-tissue accumulation C Hu, Y Huang, Y Chen - Molecular Pharmaceutics, 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.8b00854 Nrp-1 receptor targeting peptide-functionalized TPGS micellar nanosystems to deliver 10-hydroxycampothecin for enhanced cancer chemotherapy A Mozhi , I Ahmad , QM Kaleem, RG Tuguntaev - International journal of , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517318303880 Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment A Kumar , H Ma, X Zhang , K Huang, S Jin , J Liu , T Wei - Biomaterials, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961211012622 Peptide-based strategies for targeted tumor treatment and imaging A Ayo, P Laakkonen - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/4/481

• Marke: Biosynth